Submission Details
| 510(k) Number | K102210 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 05, 2010 |
| Decision Date | December 28, 2010 |
| Days to Decision | 145 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K102210 is an FDA 510(k) clearance for the LZI AMPHETAMINES 500 HOMOGENOUS ENZYME IMMUNOASSAY; LZI AMPHETAMINES 500 CALIBRATORS; LZI AMPHETAMINES 500 CONTROLS, a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ), submitted by Lin-Zhi International, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on December 28, 2010, 145 days after receiving the submission on August 5, 2010. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K102210 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 05, 2010 |
| Decision Date | December 28, 2010 |
| Days to Decision | 145 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |